Found: 18
Select item for more details and to access through your institution.
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 503, doi. 10.1111/dom.15336
- By:
- Publication type:
- Article
Comparative efficacy and safety of Gla‐300 versus IDegAsp in insulin‐naïve people with type 2 diabetes mellitus uncontrolled on oral anti‐diabetics.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2495, doi. 10.1111/dom.15121
- By:
- Publication type:
- Article
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1664, doi. 10.1111/dom.14065
- By:
- Publication type:
- Article
Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 315, doi. 10.1111/dom.13897
- By:
- Publication type:
- Article
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 321, doi. 10.1111/dom.13607
- By:
- Publication type:
- Article
Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin‐naive individuals with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2894, doi. 10.1111/dom.13450
- By:
- Publication type:
- Article
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/ mL added to oral antidiabetes agents in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1546, doi. 10.1111/dom.12966
- By:
- Publication type:
- Article
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1769, doi. 10.1007/s13300-024-01608-4
- By:
- Publication type:
- Article
Diabetesbezogene Kosten und Therapiezufriedenheit bei ICT-behandelten Typ-2-Diabetikern in der ambulanten Versorgung: Ergebnisse der LIVE-COM-Studie.
- Published in:
- Medizinische Klinik (Urban & Vogel), 2010, v. 105, n. 11, p. 792, doi. 10.1007/s00063-010-1136-1
- By:
- Publication type:
- Article
ACE inhibition and atherogenesis.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2002, v. 80, n. 4, p. 354
- By:
- Publication type:
- Article
Evaluation of the JuniorSTAR Half-unit Insulin Pen in Young People with Type 1 Diabetes - User Perspectives.
- Published in:
- European Endocrinology, 2013, v. 9, n. 2, p. 82
- By:
- Publication type:
- Article
Incidence of Hypoglycaemia in Patients with Type 2 Diabetes - A Subgroup Analysis from the GINGER study.
- Published in:
- European Endocrinology, 2013, v. 9, n. 1, p. i, doi. 10.17925/EE.2013.09.01.iI
- By:
- Publication type:
- Article
Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents -- a randomized, prospective, crossover, open clinical trial.
- Published in:
- Health & Quality of Life Outcomes, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12955-015-0279-4
- By:
- Publication type:
- Article
Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents – a randomized, prospective, crossover, open clinical trial.
- Published in:
- Health & Quality of Life Outcomes, 2015, v. 13, n. 1, p. 77, doi. 10.1186/s12955-015-0279-4
- By:
- Publication type:
- Article
Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents--a randomized, prospective, crossover, open clinical trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0548-0
- By:
- Publication type:
- Article
Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents.
- Published in:
- Diabetes Care, 2009, v. 32, p. S260, doi. 10.2337/dc09-S319
- By:
- Publication type:
- Article